Aurélie Clément Selected Research

CAC protocol

1/2010

Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aurélie Clément Research Topics

Disease

1	Osteoporosis 01/2021
1	Hearing Loss (Hearing Impairment) 01/2019
1	Deafness (Deaf Mutism) 10/2018
1	Bilateral Vestibulopathy 10/2018
1	Usher Syndromes (Usher Syndrome) 10/2018
1	Ganglion Cysts (Ganglion) 12/2013
1	Neoplasms (Cancer) 01/2010
1	Colitis-Associated Neoplasms 01/2010
1	Colitis 01/2010
1	Inflammation (Inflammations) 01/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2010

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2013
1	Coat Protein Complex I (COPI)IBA 01/2021
1	EnzymesIBA 10/2018
1	Cysteine (L-Cysteine)FDA Link 10/2018
1	Macromolecular SubstancesIBA 10/2018
1	GlutaredoxinsIBA 10/2018
1	AzoxymethaneIBA 01/2010
1	Dextrans (Dextran)FDA Link 01/2010
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2010
1	NF-kappa B (NF-kB)IBA 01/2010

Therapy/Procedure

1	CAC protocol 01/2010
1	Therapeutics 01/2010